Evidence map›Paper›PMID 30098196›Full record

ArticleInvestigative ophthalmology & visual science2018

MicroRNA-124 Dysregulation is Associated With Retinal Inflammation and Photoreceptor Death in the Degenerating Retina.

Joshua A Chu-Tan, Matt Rutar, Kartik Saxena, Riemke Aggio-Bruce, Rohan W Essex, Krisztina Valter, Haihan Jiao, Nilisha Fernando, Yvette Wooff, Michele C Madigan and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Investigative ophthalmology & visual science, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. MicroRNA expression profiling in tears and blood as predictive biomarkers for anti-VEGF treatment response in wet age-related macular degeneration.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Epigenetic Switches in Retinal Homeostasis and Target for Drug Development.International journal of molecular sciences · 2024
    Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Joshua A Chu-TanThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Matt RutarThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Kartik SaxenaThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Riemke Aggio-BruceThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Rohan W EssexAcademic Unit of Ophthalmology, The Australian National University, Canberra, Australia.
Krisztina ValterThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Haihan JiaoThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Nilisha FernandoThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Yvette WooffThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Michele C MadiganSave Sight Institute, Discipline of Clinical Ophthalmology, The University of Sydney, Sydney, Australia.
Jan ProvisThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Riccardo NatoliThe John Curtin School of Medical Research, The Australian National University, Acton, Australia.
Australian National University · AUUNSW Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: We sought to determine the role and retinal cellular location of microRNA-124 (miR-124) in a neuroinflammatory model of retinal degeneration. Further, we explored the anti-inflammatory relationship of miR-124 with a predicted messenger RNA (mRNA) binding partner, chemokine (C-C motif) ligand 2 (Ccl2), which is crucially involved in inflammatory cell recruitment in the damaged retina. Methods: Human AMD donor eyes and photo-oxidative damaged (PD) mice were labeled for miR-124 expression using in situ hybridization. PDGFRa-cre RFP mice were used for Müller cell isolation from whole retinas. MIO-M1 immortalized cells and rat primary Müller cells were used for in vitro analysis of miR-124 expression and its relationship with Ccl2. Therapeutic efficacy was tested with intravitreal administration of miR-124 mimic in mice, with electroretinography used to determine retinal function. IBA1 immunohistochemistry and photoreceptor row counts were used for assessment of inflammation and cell death. Results: MiR-124 expression was correlated with progressive retinal damage, inflammation, and cell death in human AMD and PD mice. In addition, miR-124 expression was inversely correlated to Ccl2 expression in mice following PD. MiR-124 was localized to both neuronal-like photoreceptors and glial (Müller) cells in the retina, with a redistribution from neurons to glia occurring as a consequence of PD. Finally, intravitreal administration of miR-124 mimics decreased retinal inflammation and photoreceptor cell death, and improved retinal function. Conclusions: This study has provided an understanding of the mechanism behind miR-124 in the degenerating retina and demonstrates the usefulness of miR-124 mimics for the modulation of retinal degenerations.

Indexed as

Analysis of VarianceAnimalsChemokine CCL2Disease Models, AnimalMiceMice, Inbred C57BLMicroRNAsRatsRetinaRetinal DegenerationRNA, MessengerCCL2 protein, humanChemokine CCL2MicroRNAsMirn124 microRNA, mouseRNA, Messenger

Identifiers

PMID30098196
PMCPMC11647551
OpenAlexW2886130398

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.